Financial Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc byJosh SandbergApril 17, 2019
Financial Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc. byJosh SandbergMarch 14, 2019
Biologics Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer byJosh SandbergNovember 26, 2018
Financial Osiris Therapeutics, Inc Reports Third Quarter 2018 Results byJosh SandbergNovember 8, 2018
Biologics Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada byJosh SandbergOctober 30, 2018
Biologics Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018 byJosh SandbergSeptember 18, 2018
Financial Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018 byJosh SandbergAugust 1, 2018
Biologics Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO byJosh SandbergFebruary 6, 2018
Financial Top Stories Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation byJosh SandbergNovember 3, 2017
